Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03546153
Other study ID # STUDY00141062
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2018
Est. completion date September 1, 2019

Study information

Verified date September 2019
Source University of Kansas Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

By doing this study, researchers hope to learn effects of aerobic exercise on over activated nervous system in people with chronic low back pain.


Description:

Chronic low back pain is a common condition in the world. About 85% of people with low back pain do not know the cause of their pain. This leads to ineffective treatments.

Recently, the idea of an over activated nervous system is thought to be one of the main reasons for chronic pain. Over activated nervous system means pain processing areas in the spine or brain might be more sensitive. Aerobic exercise, such as walking and cycling, is often used to decrease chronic pain. Aerobic exercise is a form of physical exercise that strengthen the heart and lungs in order to improve the body's utilization of oxygen.

The researchers want to examine if aerobic exercise is effective in decreasing over activation of the nervous system. Gaining a better understanding of effects of aerobic exercise on the nervous system may lead to more effective treatments for low back pain.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date September 1, 2019
Est. primary completion date September 1, 2019
Accepts healthy volunteers No
Gender All
Age group 21 Years to 70 Years
Eligibility Inclusion Criteria:

- Lower back pain (LBP) for more than 3 months

- A minimal pain level of 3 on the 0-10 pain numerical rating scale (NRS) in the last 7 days

- Can read and understand English.

Exclusion Criteria:

- Nerve root compression that resulted in numbness or decrease in sensation in the areas for the pain sensitivity tests as reported by the subject

- cervical or thoracic pain as a main complaint

- spinal pathologies such as fracture, tumor, infection, and severe inflammation

- severe spinal deformity

- severe cardiovascular and neurological diseases

- cancer

- history of spinal surgery

- currently seeking active treatments for LBP other than medications

- resting blood pressure more than 160/90 mmHg 49

- currently taking blood thinning medications

- uncontrolled diabetes

- cannot have blood pressure taken

- participated in a similar trial in the past

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Aerobic exercise program
Exercise program consists of training for 60 minutes, three times per week for 12 weeks. Participants will use a treadmill, Nu stepper/bike or elliptical to exercise.

Locations

Country Name City State
United States University of Kansas Medical Center Kansas City Kansas

Sponsors (1)

Lead Sponsor Collaborator
University of Kansas Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain sensitivity (Pressure pain threshold) Sensitivity will be measured using a pressure algometer. Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)
Primary 2011 FM survey Sensitivity will be measured using the 2011 Fibromyalgia (FM) Survey Criteria. The survey includes widespread pain index and symptom severity scale. The total score is 31 and scores more than 13 is considered fibromyalgia positive, suggesting presence of central sensitization. Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)
Primary Opioid consumption Use of opioids (dose, frequency, and duration) will be obtained by interviewing the subjects Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)
Primary Oswestry Disability Index This questionnaire consists of questions related to daily functions and degrees to which back pain interferes with these functions. Each items is measured on a 6-point scale with a total possible score of 50. Higher numbers indicate greater disability. Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)
Secondary Pain Sensitivity (CPM test) Measure of the functionality of descending inhibitory pain pathways with use of pressure algometry. Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)
Secondary Fear Avoidance Belief Questionnaire The survey has items related to fear about physical and work activities. Each item is scored from 0-6 points, with higher number indicating increased fear of activity or work. Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)
Secondary Pain Catastrophizing Scale PCS is a validated 13--item scale with questions related to catastrophizing behavior. Total score is 52 with higher scores indicating greater catastrophic thoughts. Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)
Secondary Beck Depression Inventory Beck depression questionnaire contains 21 multiple-choice depression related questions on a scale value of 0 to 3. Higher scores indicate greater depressive symptoms. Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)
Secondary Beck Anxiety Inventory Beck anxiety questionnaire contains 21 multiple-choice questions, each score 0 (not al all) to 3 (severely). Higher scores indicate greater anxiety symptoms. Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)
Secondary Pittsburgh Sleep Quality Index Pittsburgh sleep quality index contains 19 questions, creating 7 components that produce one global score. Higher scores indicate poorer sleep quality. Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)
Secondary Lumbar spine range of motion Lumbar spine range of motion into forward, backward, and side bending will be assessed with two inclinometers or a tape measure. subjects will Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)
See also
  Status Clinical Trial Phase
Completed NCT03243084 - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Completed NCT03162952 - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed NCT03240146 - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain N/A
Completed NCT05282589 - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients N/A
Completed NCT03637998 - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain N/A
Recruiting NCT02289170 - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) N/A
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Completed NCT02231554 - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial N/A
Recruiting NCT02063503 - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients N/A
Completed NCT01704677 - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up N/A
Terminated NCT01620775 - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain N/A
Completed NCT01177280 - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes N/A
Completed NCT01177254 - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions N/A
Completed NCT01177241 - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids N/A
Completed NCT01490905 - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain Phase 4
Completed NCT00984815 - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Phase 3
Completed NCT00761150 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00767806 - A Study for Patient With Chronic Low Back Pain Phase 3
Completed NCT00763321 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3